While increased levels of 2N and 4R tau isoforms were observed in PSP and CBD patients, the lack of post-mortem pathological confirmation and incomplete evaluation of post-translational modifications, such as acetylation and ubiquitination, limit the broader clinical applicability of these findings [50]. The gene discussed is MAPT; the disease is red-green color blindness.